期刊文献+

SPARC基因过表达对SKM-1细胞凋亡的影响

Effects of SPARC Gene Overexpression on Proliferation and Apoptosis of SKM-1 Cells
原文传递
导出
摘要 构建SPARC基因过表达载体,转染人骨髓增生异常综合征(myelodysplastic syndrome,MDS)细胞系SKM-1细胞,探讨SPARC基因过表达对人MDS细胞系SKM-1细胞凋亡的影响。以pcDNA-SPARC为引物,PCR扩增SPARC基因;将靶基因克隆入慢病毒载体pGC-GV,构建含有SPARC基因的重组慢病毒载体pGC-GV-SPARC,测序检测正确性;将构建载体pGC-GV-SPARC转染人MDS细胞系SKM-1,流式细胞术检测转染效率,RT-PCR检测SKM-1细胞中SPARC mRNA表达,Western blot检测SPARC蛋白表达,MTS法测定小剂量阿糖胞苷(30 ng/mL)对实验组增殖抑制的影响,Annexin V检测SPARC基因转染后对人SKM-1细胞凋亡的影响。结果显示,构建含有SPARC基因的重组慢病毒载体pGC-GV-SPARC转染效率为(64.25±1.42)%;转染后,SPARC mRNA及蛋白表达在靶细胞中较对照组增多。小剂量阿糖胞苷对转染组的增殖抑制率明显高于其他组。SPARC基因转染后人SKM-1细胞凋亡率较未转染组明显增高,加入阿糖胞苷后人SKM-1细胞凋亡率较对照组明显增高。由此说明,作者成功构建了携带人SPARC基因的慢病毒载体,转染人SKM-1细胞系后稳定表达SPARC基因,SPARC过表达可抑制细胞增殖,且联合小剂量阿糖胞苷(30 ng/mL)更有效地抑制SKM-1细胞的增殖,并诱导其凋亡。 To construct a recombinant lentiviral vector carrying SPARC gene, we investigated the altera- tion on the proliferation of MDS cell line SKM-I cells. The SPARC was obtained using pcDNA-SPARC by PCR. The SPARC gene was cloned into a lentiviral vector pGC-GV to construct a recombinant lentiviral vector carrying SPARC gene named pGC-GV-SPARC, which was confirmed to be correct by DNA sequencing, pGC-GV-SPARC was used to transfect human MDS cell line SKM-1. The transfection efficiency, SPARC mRNA and protein ex- pression were detected by flow cytometry, RT-PCR and Western blot, respectively. The MTS method was used to determine inhibition effects of low doses of Ara-C in different groups. Results showed that the recombinant len- tiviral vector pGC-GV-SPARC was confirmed to be correct by DNA sequencing. The transfection efficiency was (64.25±1.42)%, and stably expressed. PT-PCR and Western blot showed that the expression of SPARC was increased. MTS results showed that the proliferation effect of low doses of Ara-C on the inhibition rate of transfection group was significantly higher than those of negative group and SKM-1 group. The results showed that lentiviral vector carrying SP4RC was constructed successfully, and the expression of SPARC could effectively increased by pGC-GV- SPARC, which could inhibit the proliferation of SKM- 1 cell and promote its apoptosis by combining with low doses of Ara-C.
出处 《中国细胞生物学学报》 CAS CSCD 北大核心 2014年第4期502-508,共7页 Chinese Journal of Cell Biology
基金 国家自然科学基金(批准号:81250034 30971277) 重庆市科委基金(批准号:CSTC2009BB5070)资助的课题~~
关键词 SPARC基因 阿糖胞苷 慢病毒载体 骨髓增生异常综合征 SPARC gene cytosine arabinoside lentiviral vector myelodysplastic syndrome
  • 相关文献

参考文献1

二级参考文献11

  • 1陈葆国,朱敏,罗文达,颜卫华,周美英,李伯利,陶丹丹.骨髓增生异常综合征PTEN基因表达和Akt磷酸化水平的相关性研究[J].中华血液学杂志,2007,28(7):470-473. 被引量:8
  • 2Steelman LS, Abrams SL, Whelan J, et al. Contributions of the Raf/MEK/ERK, PI3 K/PTEN/Akt/mTOR and Jak/STAT pathways to leukemia. Leukemia, 2008 ;22 (4) : 686 - 707.
  • 3Nishioka C, Ikezoe T, Yang J, et al. Blockade of roTOR signaling potentiates the ability of histone deacetylase inhibitor to induce growth arrest and differentiation of acute myelogenous leukemia cells. Leukemia, 2008 ;22(12) :2159 -2168.
  • 4Kharas MG, Janes MR, Scarfone VM, et al. Ablation of PI3K blocks BCR-ABL leukemogenesis in mice, and a dual PI3K/mTOR inhibitor prevents expansion of human BCR-ABL^+ leukemia cells. J Clin Invest, 2008 ;118(9) :3038 -3050.
  • 5Gu L, Gao J, Li Q, et al. Rapamycin reverses NPM-ALK-induced glucocorticoid resistance in lymphoid tumor ceils by inhibiting mTOR signaling pathway, enhancing G1 cell cycle arrest and apoptosis. Leukemia, 2008 ;22( 11 ) :2091 -2096.
  • 6Recher C, Beyne-Ranzy O, Demur C, et al. Antileukemic activit of rapamycin in acute myeloid leukemia . Blood, 2005 ; 105 ( 6 ) : 2527 - 2534.
  • 7Ding H, Zhang C, Wu X, et al. Novel indole alpha-methylene- gamma-lactones as potent inhibitors for AKT-mTOR signaling pathway kinases. Bioorg Med Chem Lett, 2005;15(21 ) :4799 - 4802.
  • 8Folio MY, Mongiorgi S, Bosi C, et al. The Akt/Mammalian target of rapamycin signal transduction pathway Is activated in high- risk myelodysplastic syndromes and influences cell survival and proliferation. Cancer Res, 2007 ; 67 ( 9 ) :4287 - 4294.
  • 9Fingar DC , Blenis J. Target of rapamycin(TOR) : an integrator of nutrient and growth factor signals and coordinatorof cell growth and cell cycle progression. Oncogene,2004 ;23 ( 18 ) :3151 - 3171.
  • 10Cheng ZY, Guo XL, Yang XY, et al. PTEN and rapamycin inhibiting the growth of K562 cells through regulating mTOR signaling pathway. J Exp Clin Cancer Res, 2008 ;27:87.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部